182 related articles for article (PubMed ID: 32606465)
1. CRISPR gene editing in human embryos wreaks chromosomal mayhem.
Ledford H
Nature; 2020 Jul; 583(7814):17-18. PubMed ID: 32606465
[No Abstract] [Full Text] [Related]
2. The CRISPR-baby scandal: what's next for human gene-editing.
Cyranoski D
Nature; 2019 Feb; 566(7745):440-442. PubMed ID: 30809070
[No Abstract] [Full Text] [Related]
3. Narrow path charted for editing genes of human embryos.
Cohen J
Science; 2020 Sep; 369(6509):1283. PubMed ID: 32913081
[No Abstract] [Full Text] [Related]
4. Therapeutic Germline Editing: Sense and Sensibility.
Adashi EY; Cohen IG
Trends Genet; 2020 May; 36(5):315-317. PubMed ID: 31982142
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for inborn errors of immunity: Base editing comes into play.
Malech HL; Notarangelo LD
Cell; 2023 Mar; 186(7):1302-1304. PubMed ID: 37001495
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 therapeutics for liver diseases.
Aravalli RN; Steer CJ
J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Therapeutic Genome Editing in China.
Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
Alanis-Lobato G; Zohren J; McCarthy A; Fogarty NME; Kubikova N; Hardman E; Greco M; Wells D; Turner JMA; Niakan KK
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050011
[TBL] [Abstract][Full Text] [Related]
10. [A new milestone in human embryo editing].
Jordan B
Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
[TBL] [Abstract][Full Text] [Related]
11. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
Wu SS; Li QC; Yin CQ; Xue W; Song CQ
Theranostics; 2020; 10(10):4374-4382. PubMed ID: 32292501
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
Zhang X; Wang L; Liu M; Li D
Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
[TBL] [Abstract][Full Text] [Related]
13. The ethics of creating genetically modified children using genome editing.
Ishii T
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
[TBL] [Abstract][Full Text] [Related]
14. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
Gumer JM
New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
[TBL] [Abstract][Full Text] [Related]
15. Genome editing for the reproduction and remedy of human diseases in mice.
Hara S; Takada S
J Hum Genet; 2018 Feb; 63(2):107-113. PubMed ID: 29180644
[TBL] [Abstract][Full Text] [Related]
16. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
Plaza Reyes A; Lanner F
Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
[TBL] [Abstract][Full Text] [Related]
17. Geneticists retract study suggesting first CRISPR babies might die early.
Callaway E
Nature; 2019 Oct; 574(7778):307. PubMed ID: 31616098
[No Abstract] [Full Text] [Related]
18. Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.
Leibowitz ML; Papathanasiou S; Doerfler PA; Blaine LJ; Sun L; Yao Y; Zhang CZ; Weiss MJ; Pellman D
Nat Genet; 2021 Jun; 53(6):895-905. PubMed ID: 33846636
[TBL] [Abstract][Full Text] [Related]
19. Marker-free genome editing in Ustilago trichophora with the CRISPR-Cas9 technology.
Huck S; Bock J; Girardello J; Gauert M; Pul Ü
RNA Biol; 2019 Apr; 16(4):397-403. PubMed ID: 29996713
[TBL] [Abstract][Full Text] [Related]
20. Prime Time for Genome Editing?
Urnov FD
N Engl J Med; 2020 Jan; 382(5):481-484. PubMed ID: 31995698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
